Circulating endothelial cells in oncology: pitfalls and promises
about
Endothelial progenitor cells in diabetic retinopathyMeningitic Escherichia coli K1 penetration and neutrophil transmigration across the blood-brain barrier are modulated by alpha7 nicotinic receptorDetection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies.Circulation of progenitor cells in obese and lean colorectal cancer patientsA prospective pilot study of circulating endothelial cells as a potential new biomarker in portal hypertension.Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancerA new approach for rapid and reliable enumeration of circulating endothelial cells in patients.Human endothelial stem/progenitor cells, angiogenic factors and vascular repair.Circulating brain microvascular endothelial cells (cBMECs) as potential biomarkers of the blood-brain barrier disorders caused by microbial and non-microbial factors.A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.Levels of circulating CD45(dim)CD34(+)VEGFR2(+) progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitorsCirculating endothelial cells and circulating endothelial precursor cells in patients with osteosarcoma.Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.Angiogenesis inhibitors in the treatment of non-small cell lung cancerPrognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB tCirculating tumor cells measurements in hepatocellular carcinoma.Vimentin, a Novel NF-κB Regulator, Is Required for Meningitic Escherichia coli K1-Induced Pathogen Invasion and PMN Transmigration across the Blood-Brain BarrierThe association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon.Flow cytometric analysis of circulating endothelial cells and endothelial progenitors for clinical purposes in oncology: A critical evaluation.A systematic approach to the establishment and characterization of endothelial progenitor cells for gene therapy.Antiangiogenic drugs in ovarian cancer.Towards novel radiosensitizing agents: the role of cytosolic PLA2α in combined modality cancer therapy.Endothelial dysfunction in the regulation of cirrhosis and portal hypertension.Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.Cytosolic phospholipase A2: targeting cancer through the tumor vasculature.Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry.Endothelial progenitors as tools to study vascular disease.Endothelial CD276 (B7-H3) expression is increased in human malignancies and distinguishes between normal and tumour-derived circulating endothelial cells.Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy.A six-colour flow cytometric method for simultaneous detection of cell phenotype and apoptosis of circulating endothelial cells.Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method.Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer.Profiles of circulating endothelial cells and serum cytokines during adjuvant chemoradiation in rectal cancer patients.
P2860
Q26827206-C82B2075-D84A-41AF-B5EA-5E3D796784F7Q31031689-45D7AAF1-0642-44E1-B218-40E8BC66FADBQ33551239-8A0CDFA5-6FEA-4364-8A97-20D0992FBD69Q33581969-B0ADB88D-4C7C-4C78-82CA-A617C6F10AC4Q33796332-5E2D8965-E1B6-4D9E-A7D5-B91F007E5ED6Q33843701-9C85B192-DD42-4D97-B672-69D295B2518BQ34128953-A6179E1C-A954-4800-BA90-9E4B646659D6Q34183354-7BAC68B2-7FF8-44C3-8747-713FEA0A6F16Q34333348-9CFC5209-89EE-495B-BABA-90D26013EB5BQ34701013-F6367E57-2190-454C-8220-39C3D3651FEAQ34703792-2C647BCA-0478-4AA3-989E-4993FEB8BE7AQ34745991-734F62D3-D900-4D7E-BA23-F8202B7FCDA7Q34762886-08657D44-8A42-4F5F-9F99-67F89C9C87F0Q34779133-33B2A2CB-D4DC-4DFF-A261-DB2B907A218EQ35076198-3D545FBC-89FA-4653-BCA6-D12450B50A92Q35863148-EA155099-8C5C-4AC9-A13C-BE50627CD32DQ36011412-50E54A22-FCD8-4815-A153-DCA87FDAB781Q36140728-BFB4A2BC-5EEC-408A-A2D1-4D141DFCA88FQ36614297-28B1085C-560D-434F-94E3-A9700C815996Q36954000-F0431760-FF3D-4A4A-BB9F-9FE9337F12C9Q37066330-B3A3348B-C330-46ED-9BDC-1677A557CAD9Q37080913-B3DDC80F-B83F-4CFA-BD47-BA326A9F879EQ37885347-797273AE-65F4-4816-AC37-EB6C7D159EBBQ37899947-09D53C27-0EB8-49EB-8B27-0A6B698C1AB6Q38085411-BDC3AF48-126F-4A01-9019-009403810C87Q39263457-9E1A40E4-FF92-4876-9BC2-157D513391EDQ40689319-1E336CEE-3D6D-4B3B-AD4F-81FEE36CEF40Q40952760-6E9A9007-BFBA-4A79-9996-D4B7088BEF1CQ41836574-1DE25654-498D-410F-830C-22958555639EQ42728633-DF4E1F77-3781-4B5B-94EC-007D7E0CFFF1Q43127349-7D96E486-E975-43D7-823E-1378CD64F794Q46165524-4E259F16-6E82-4584-8AAB-AE9D5E690F7DQ47397525-DD5D0C53-E586-4054-A328-3CC7F384716DQ47402499-C4C380C1-8D88-47D9-9DA3-DA95C4DEB336Q48018929-56A6A43D-86A4-40A7-B25E-7CB5F18CCD93Q53120624-90EBEF0E-EC7D-45E5-B0FF-7D2DBA54E4EA
P2860
Circulating endothelial cells in oncology: pitfalls and promises
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Circulating endothelial cells in oncology: pitfalls and promises
@en
Circulating endothelial cells in oncology: pitfalls and promises.
@nl
type
label
Circulating endothelial cells in oncology: pitfalls and promises
@en
Circulating endothelial cells in oncology: pitfalls and promises.
@nl
prefLabel
Circulating endothelial cells in oncology: pitfalls and promises
@en
Circulating endothelial cells in oncology: pitfalls and promises.
@nl
P2093
P2860
P921
P356
P1476
Circulating endothelial cells in oncology: pitfalls and promises
@en
P2093
C H Lamers
J W Gratama
M A den Bakker
M H Strijbos
S Sleijfer
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604383
P407
P577
2008-05-27T00:00:00Z
2008-06-03T00:00:00Z
P5875
P6179
1035947940